A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of UCB7858 in Adult Kidney Transplant Recipients With Chronic Allograft Injury
Condition: Chronic Allograft Injury Interventions: Drug: UCB7858; Drug: Placebo Sponsor: UCB Biopharma SRL Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Graft | Kidney Transplant | Kidney Transplantation | Research | Study | Transplant Surgery | Transplants | Urology & Nephrology